The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
VYNE Therapeutics Inc(NASDAQ:VYNE) 
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age...
Website: http://www.vynetherapeutics.com
Founded: 2003
CEO: David Domzalski
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
VYNE Therapeutics Days Payable Outstanding ttm (DPO)
VYNE Therapeutics Days Receivable Outstanding ttm (DSO)
VYNE Therapeutics Op Cashflow Per Share ttm
VYNE Therapeutics Free Cashflow Per Share ttm
VYNE Therapeutics Cash Per Share ttm
VYNE Therapeutics P/S ratio ttm
VYNE Therapeutics (GAAP) P/E ratio ttm
VYNE Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.